{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:44:48Z","timestamp":1787867088887,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"DOI":"10.7759\/cureus.98014","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T14:39:15Z","timestamp":1764340755000},"source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Study of Rabbit Anti-T Lymphocyte Globulin (rATLG) as a Second-Line Therapy in Transplant-Ineligible Severe Aplastic Anemia Patients"],"prefix":"10.7759","author":[{"given":"Aritra","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra P","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swasti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Raghuveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Middinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern AE","year":"2021","unstructured":"DeZern AE, Churpek JE. Approach to the diagnosis of aplastic anemia. Blood Adv. 2021, 5:2660-71. 10.1182\/bloodadvances.2021004345","journal-title":"Blood Adv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young NS","year":"2018","unstructured":"Young NS. Aplastic anemia. N Engl J Med. 2018, 379:1643-56. 10.1056\/NEJMra1413485","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj A","year":"2024","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I, et al.. Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline. Br J Haematol. 2024, 204:784-804. 10.1111\/bjh.19236","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour R","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, et al.. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022, 386:11-23. 10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jpgm.JPGM_391_18","article-title":"Access to hematopoietic stem-cell transplantation in India","volume":"65","author":"Kulkarni U","year":"2019","unstructured":"Kulkarni U, George B. Access to hematopoietic stem-cell transplantation in India. J Postgrad Med. 2019, 65:1-4. 10.4103\/jpgm.JPGM_391_18","journal-title":"J Postgrad Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0037-1963(00)90030-1","article-title":"Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine","volume":"37","author":"Frickhofen N","year":"2000","unstructured":"Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000, 37:56-68. 10.1016\/s0037-1963(00)90030-1","journal-title":"Semin Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg P","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011, 365:430-8. 10.1056\/NEJMoa1103975","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15342","article-title":"Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation","volume":"19","author":"Alloway RR","year":"2019","unstructured":"Alloway RR, Woodle ES, Abramowicz D, et al.. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation. Am J Transplant. 2019, 19:2252-61. 10.1111\/ajt.15342","journal-title":"Am J Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2018.03.001","article-title":"The pathophysiology of acquired aplastic anemia: current concepts revisited","volume":"32","author":"Schoettler ML","year":"2018","unstructured":"Schoettler ML, Nathan DG. The pathophysiology of acquired aplastic anemia: current concepts revisited. Hematol Oncol Clin North Am. 2018, 32:581-94. 10.1016\/j.hoc.2018.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.11.676","article-title":"Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation","volume":"21","author":"Storek J","year":"2015","unstructured":"Storek J, Mohty M, Boelens JJ. Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015, 21:959-70. 10.1016\/j.bbmt.2014.11.676","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06098.x","article-title":"Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia","volume":"133","author":"Scheinberg P","year":"2006","unstructured":"Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol. 2006, 133:622-7. 10.1111\/j.1365-2141.2006.06098.x","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01693.x","article-title":"Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO)","volume":"107","author":"Di Bona E","year":"1999","unstructured":"Di Bona E, Rodeghiero F, Bruno B, et al.. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol. 1999, 107:330-4. 10.1046\/j.1365-2141.1999.01693.x","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14075","article-title":"Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia","volume":"111","author":"Sakamoto T","year":"2023","unstructured":"Sakamoto T, Obara N, Maruyama Y, et al.. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Eur J Haematol. 2023, 111:768-76. 10.1111\/ejh.14075","journal-title":"Eur J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2014.12.002","article-title":"Rabbit antithymocyte globulin as first-line therapy for severe aplastic anemia","volume":"43","author":"Zhang L","year":"2015","unstructured":"Zhang L, Jing L, Zhou K, et al.. Rabbit antithymocyte globulin as first-line therapy for severe aplastic anemia. Exp Hematol. 2015, 43:286-94. 10.1016\/j.exphem.2014.12.002","journal-title":"Exp Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418767-a-retrospective-study-of-rabbit-anti-t-lymphocyte-globulin-ratlg-as-a-second-line-therapy-in-transplant-ineligible-severe-aplastic-anemia-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T14:39:16Z","timestamp":1764340756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418767-a-retrospective-study-of-rabbit-anti-t-lymphocyte-globulin-ratlg-as-a-second-line-therapy-in-transplant-ineligible-severe-aplastic-anemia-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.98014","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}